Very impressive presentation by ZR at the AGM, but the...

Very impressive presentation by ZR at the AGM, but the presentations have been impressive every other year and still we wait. Nevertheless, I remain hopeful (but no more than that) that a breakthrough will come. There are some large markets that their products address (AIDS, cancer side effects, flu, type II diabetes, among others). Also, development times are relatively short and regulatory hurdles few.

I'm worried about capital, though. They no longer have the sideline manufacturing business to bring in cash and the share price remains very low, so new issues to raise funds will be very dilutory.

ZR gave an assurance that the company would survive the current financial turmoil.

Pezz